BIO calls for approval of biotech salmon

05/1/2013 | BiofuelsDigest.com

BIO encouraged the FDA to approve AquaBounty Technologies' AquAdvantage biotech salmon, saying that all scientific steps required for regulatory approval have been completed. "This evaluation has been thorough. It is past time to provide a decision and let the market determine whether it supports this innovation that produces healthy food in a sustainable manner by using inland farms to help us meet global protein needs," said David Edwards, BIO's director of animal biotechnology.

View Full Article in:

BiofuelsDigest.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN